Common use of Batch Fee Clause in Contracts

Batch Fee. o For each Batch manufactured in accordance with Procedures, which complies with the Specifications and the other applicable terms of this Agreement, the Single Batch Fee will be *****. o If exactly two Batches are manufactured approximately in parallel/at approximately the same time, the Double Batch Fee for both Batches manufactured in accordance with Procedures and which comply with the Specifications and the other applicable terms of this Agreement, will be ***** for both batches. o The price of the leukocytes and plasma required to manufacture a Batch ordered under the Supply Agreement, if sourced from ARC, shall be ***** per Batch, which shall be payable under the Supply Agreement. Such price shall be inclusive of the tests that are normally performed on whole blood units including, testing of the donated blood for blood-borne pathogens to include: anti-HCV; HBsAg; anti-HIV 1&2; anti-HTLV Iⅈ HCV; HIV; HBV; Syphilis, CMV, HBV core antigen. The complete schedule of such tests included in the ***** price per Batch shall be detailed in the Quality Agreement. In the event that the Parties agree that additional tests (which are not normally performed on whole blood units) shall be performed on the Batches (e.g. Complete Blood Count) pricing shall be the subject of good faith negotiations between the Parties and shall reflect the actual cost of such testing to ARC. All Batch Fees will include corresponding MacroCure finished Products. The Single Batch Fees and the Double Batch Fees are exclusive of the ▇▇-▇▇ and plasma which are covered under separate agreement but are inclusive of the QC Assays listed below which are to be performed by ARC as part of the manufacturing of the Batches and Products. o There shall be no Single Batch Fee or Double Batch Fee for the Batch and/or Products manufactured as part of Technology Transfer. In addition, there shall be no payment by MacroCure for the first fifty (50) units of leukoctyes and plasma (including no payment for the relevant testing specified above) which are required to manufacture the Batches and/or Products manufactured as part of the Technology Transfer. ARC shall have the option of charging Macrocure for any leukoctyes and plasma (including no payment for the relevant testing specified above) which are required to manufacture the Batches and/or Products manufactured as part of the Technology Transfer above the first fifty (50) units manufactured as a part of the Technology Transfer. The price of such Products above 50 units manufactured as a part of the Technology Transfer shall be negotiated in good faith between the Parties, but shall in no event exceed the $150 per Batch fee.